CCAIM
Novel AI to transform healthcare
An extensive new study published in Nature Machine Intelligence shows that a prognostic tool developed by the van der Schaar Lab can recommend therapies for breast cancer patients more reliably than methods …
Using AI with home monitoring to predict sudden dips in the health of adults with cystic fibrosis has been awarded ‘Phase 2’ funding by the government. A pioneering artificial intelligence …
Dr. Alexander Gimson is leading Britain’s national team dedicated to improving the country’s existing organ allocation scheme to save more lives. Dr. Gimson and colleagues at the van der Schaar …
Members of the CCAIM research team will publish ten papers at this year’s International Conference on Machine Learning (ICML), the leading international academic conference in machine learning. Taking place completely …
The van der Schaar Lab has developed a machine learning solution that goes beyond the scope of contemporary organ-to-patient matching policies by also accounting for the rarity of organs available …
Scientists have been able to track how a multi-drug resistant organism is able to evolve and spread widely among cystic fibrosis patients – showing that it can evolve rapidly within …
This report adds detail to existing findings in wider tech sector studies that workforce diversity has stagnated, now on-par with the 1990s in relative terms within AI. We discussed the findings with Mihaela Van Der Schaar, the most-cited female AI researcher in the UK from the data set.
